The second PGD2 receptor CRTH2: Structure, properties, and functions in leukocytes

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 69, Issue 2-3, 2003, Pages 169-177

  Nagata, Kinya ^a   Hirai, Hiroyuki ^a  

^a BioMedical Laboratories Inc   (Japan)

Author keywords

Allergy; G protein coupled receptor; Prostaglandin D2

Indexed keywords

11 EPIPROSTAGLANDIN F2 ALPHA; 15 DEOXY DELTA12,14 PROSTAGLANDIN J2; 15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 3 BENZYL 5 (6 CARBOXYHEXYL) 1 (2 CYCLOHEXYL 2 HYDROXYETHYLAMINO)HYDANTOIN; 5 (6 CARBOXYHEXYL) 1 (3 CYCLOHEXYL 3 HYDROXYPROPYL)HYDANTOIN; ACEMETACIN; ACETYLSALICYLIC ACID; CHEMOATTRACTANT RECEPTOR; DELTA12 PROSTAGLANDIN J2; DICLOFENAC; INDOMETACIN; LIGAND; PROSTAGLANDIN D2; PROSTAGLANDIN E2; PROSTAGLANDIN J2; PROSTAGLANDIN RECEPTOR; RECEPTOR; SULINDAC; UNCLASSIFIED DRUG;

ALLERGY; BASOPHIL; CELL FUNCTION; EOSINOPHIL; HUMAN; INFLAMMATION; LEUKOCYTE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; TH2 CELL; TISSUE DISTRIBUTION;

EID: 0038138607     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-3278(03)00078-4     Document Type: Article

References (76)

1. R.A. Coleman, I. Kennedy, P.P.A. Humphrey, K. Bunce, P. Lumley, Prostanoids and their receptors, in: J.C. Emmett (Ed.), Comprehensive Medical Chemistry Membranes and Receptor, Vol. 3, Pergamon Press, Oxford, 1990, pp. 643-714.
2. R.A. Coleman, S.P. Grix, S.A. Head, J.B. Louttit, A. Mallett, R.L. Sheldrick, A novel inhibitory prostanoid receptor in piglet saphenous vein, Prostaglandins 47 (1994) 151-168.
3. S. Narumiya, Y. Sugimoto, F. Ushikubi, Prostanoid receptors: structures, properties, and functions, Physiol. Rev. 79 (1999) 1193-1226.
4. R.M. Breyer, C.K. Bagdassarian, S.A. Myers, M.D. Breyer, Prostanoid receptors: subtypes and signaling, Annu. Rev. Pharmacol. Toxicol. 41 (2001) 661-690.
5. M. Hirata, A. Kakizuka, M. Aizawa, F. Ushikubi, S. Narumiya, Molecular characterization of a mouse prostaglandin D receptor and functional expression of the cloned gene, Proc. Natl. Acad. Sci. USA 91 (1994) 11192-11196.
6. H. Giles, P. Leff, The biology and pharmacology of PGD2, Prostaglandins 35 (1988) 277-300.
7. 2: a biochemical perspective, Prostaglandins Leukot. Essent. Fatty Acids 37 (1989) 219-234.
8. 2, a cerebral sleep-inducing substance in rats, Proc. Natl. Acad. Sci. USA 80 (1983) 1735-1737.
9. 2 in the hypothermia of rats caused by bacterial lipopolysaccharide, Proc. Natl. Acad. Sci. USA 79 (1982) 6093-6097.
10. 2 on pulsatile luteinizing hormone release in conscious castrated rats, Endocrinology 110 (1982) 2207-2209.
11. 2 alpha to conscious mice, Eur. J. Pharmacol. 122 (1986) 173-179.
12. 2 on platelet aggregation in different species, Prostaglandins 16 (1978) 373-388.
13. 2 inhibits inducible nitric oxide synthase expression in rat vascular smooth muscle cells, Circ. Res. 82 (1998) 204-209.
14. 2 and its analogues, Br. J. Pharmacol. 85 (1985) 367-375.
15. 2 and reproduction, Am. J. Reprod. Immunol. 47 (2002) 295-302.
16. 2 generation after activation of rat and human mast cells with anti-IgE, J. Immunol. 129 (1982) 1627-1631.
17. B.J. Whittle, S. Moncada, K. Mullane, J.R. Vane, Platelet and cardiovascular activity of the hydantoin BW245C, a potent prostaglandin analogue, Prostaglandins 25 (1983) 205-223.
18. D.H. Wright, K.M. Metters, M. Abramovitz, A.W. Ford-Hutchinson, Characterization of the recombinant human prostanoid DP receptor and identification of L-644, 698, a novel selective DP agonist, Br. J. Pharmacol. 123 (1998) 1317-1324.
19. 2, Invest. Ophthalmol. Vis. Sci. 31 (1990) 138-146.
20. B. Fernandes, D. Crankshaw, Functional characterization of the prostanoid DP receptor in human myometrium, Eur. J. Pharmacol. 283 (1995) 73-81.
21. D.F. Woodward, C.S. Spada, S.B. Hawley, L.S. Williams, C.E. Protzman, A.L. Nieves, Further studies on ocular responses to DP receptor stimulation, Eur. J. Pharmacol. 230 (1993) 327-333.
22. 2 on canine proximal colon, Am. J. Physiol. 264 (1993) G886-894.
23. P.K. Rangachari, P.A. Betti, E.T. Prior, L.J. Roberts II, Effects of a selective DP receptor agonist (BW 245C) and antagonist (BW A868C) on the canine colonic epithelium: an argument for a different DP receptor?, J. Pharmacol. Exp. Ther. 275 (1995) 611-617.
24. 2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2, J. Exp. Med. 193 (2001) 255-261.
25. 2 is a potent chemoattractant for human eosinophils that acts via a novel DP receptor, Blood 98 (2001) 1942-1948.
26. K. Nagata, K. Tanaka, K. Ogawa, et al., Selective expression of a novel surface molecule by human Th2 cells in vivo, J. Immunol. 162 (1999) 1278-1286.
27. K. Nagata, H. Hirai, K. Tanaka, et al., CRTH2, an orphan receptor of T-helper-2-cells, is expressed on basophils and eosinophils and responds to mast cell-derived factor(s), FEBS Lett. 459 (1999) 195-199.
28. 2 by human helper t cell subsets, J. Immunol. 164 (2000) 2277-2280.
29. T. Ishizaka, K. Ishizaka, Activation of mast cells for mediator release through IgE receptors, Prog. Allergy. 34 (1984) 188-235.
30. E.N. Charlesworth, A.F. Hood, N.A. Soter, A. Kagey-Sobotka, P.S. Norman, L.M. Lichtenstein, Cutaneous late-phase response to allergen. Mediator release and inflammatory cell infiltration, J. Clin. Invest. 83 (1989) 1519-1526.
31. D.S. Robinson, Q. Hamid, S. Ying, et al., Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma, N. Engl. J. Med. 326 (1992) 298-304.
32. B.O. Gerber, M.P. Zanni, M. Uguccioni, et al., Functional expression of the eotaxin receptor CCR3 in T lymphocytes colocalizing with eosinophils, Curr. Biol. 7 (1997) 836-843.
33. H. Abe, T. Takeshita, K. Nagata, et al., Molecular cloning, chromosome mapping and characterization of the mouse CRTH2 gene, a putative member of the leukocyte chemoattractant receptor family, Gene 227 (1999) 71-77.
34. P.M. Murphy, The molecular biology of leukocyte chemoattractant receptors, Annu. Rev. Immunol. 12 (1994) 593-633.
35. T. Yokomizo, K. Kato, K. Terawaki, T. Izumi, T. Shimizu, Asecond leukotriene B(4) receptor, BLT2. A new therapeutic target in inflammation and immunological disorders, J. Exp. Med. 192 (2000) 421-432.
36. T. Izumi, T. Yokomizo, H. Obinata, H. Ogasawara, T. Shimizu, Leukotriene receptors: classification, gene expression, and signal transduction, J. Biochem. (Tokyo) 132 (2002) 1-6.
37. 2 are potent activators of human eosinophils, J. Immunol. 168 (2002) 3563-3569.
38. W. Cookson, The alliance of genes and environment in asthma and allergy, Nature 402 (1999) B5-11.
39. S.C. Hsu, L.C. Chen, M.L. Kuo, J.L. Huang, S.K. Huang, Novel SNPs in a candidate gene, CRTH2, for allergic diseases, Genes Immun. 3 (2002) 114-116.
40. A. Marchese, M. Sawzdargo, T. Nguyen, et al., Discovery of three novel orphan G-protein-coupled receptors, Genomics 56 (1999) 12-21.
41. H. Tsuda, T. Michimata, M. Sakai, K. Nagata, M. Nakamura, S.A. Saito, A novel surface molecule of Th2- and Tc2-type cells, CRTH2 expression on human peripheral and decidual CD4+ and CD8+ T cells during the early stage of pregnancy, Clin. Exp. Immunol. 123 (2001) 105-111.
42. 2-mediated manner, Mol. Hum. Reprod. 8 (2002) 181-187.
43. L. Cosmi, F. Annunziato, M.I.G. Galli, R.M.E. Maggi, K. Nagata, S. Romagnani, CRTH2 is the most reliable marker for the detection of circulating human type 2 Th and type 2T cytotoxic cells in health and disease, Eur. J. Immunol. 30 (2000) 2972-2979.
44. F. Annunziato, L. Cosmi, R. Manetti, et al., Reversal of human allergen-specific CRTH2 + T(H)2 cells by IL-12 or the PS-DSP30 oligodeoxynucleotide, J. Allergy Clin. Immunol. 108 (2001) 815-821.
45. 2 receptor CRTH2 with circulating T helper 2 cells in patients with atopic dermatitis, J. Invest. Dermatol. 119 (2002) 609-616.
46. L. Cosmi, F. Annunziato, G. Galli, R. Manetti, E. Maggi, S. Romagnani, CRTH2: marker for the detection of human TH2 and TC2 cells, Adv. Exp. Med. Biol. 495 (2001) 25-29.
47. T. Nakajima, K. Matsumoto, H. Suto, et al., Gene expression screening of human mast cells and eosinophils using high-density oligonucleotide probe arrays: abundant expression of major basic protein in mast cells, Blood 98 (2001) 1127-1134.
48. H.W. Ziegler-Heitbrock, Heterogeneity of human blood monocytes: the CD14+ CD16+ subpopulation, Immunol. Today. 17 (1996) 424-428.
49. K.U. Belge, F. Dayyani, A. Horelt, et al., The proinflammatory CD14 + CD16 + DR + + monocytes are a major source of TNF, J. Immunol. 168 (2002) 3536-3542.
50. B. Steppich, F. Dayyani, R. Gruber, R. Lorenz, M. Mack, H.W. Ziegler-Heitbrock, Selective mobilization of CD14(+)CD16(+) monocytes by exercise, Am. J. Physiol. Cell Physiol. 279 (2000) C578-586.
51. W.C. Greene, W.J. Leonard, The human interleukin-2 receptor, Annu. Rev. Immunol. 4 (1986) 69-95.
52. F. Sallusto, E. Kremmer, B. Palermo, et al., Switch in chemokine receptor expression upon TCR stimulation reveals novel homing potential for recently activated T cells, Eur. J. Immunol. 29 (1999) 2037-2045.
53. S.S. Ferguson, W.E. Downey III, A.M. Colapietro, L.S. Barak, L. Menard, M.G. Caron, Role of beta-arrestin in mediating agonist-promoted G protein-coupled receptor internalization, Science 271 (1996) 363-366.
54. 2 receptor, CRTH2, J. Immunol. 168 (2002) 981-985.
55. V.E. Stubbs, P. Schratl, A. Hartnell, et al., Indomethacin causes prostaglandin D(2)-like and eotaxin-like selective responses in eosinophils and basophils, J. Biol. Chem. 277 (2002) 26012-26020.
56. 2 is a ligand for the adipocyte determination factor PPAR gamma, Cell 83 (1995) 803-812.
57. J.M. Lehmann, J.M. Lenhard, B.B. Oliver, G.M. Ringold, S.A. Kliewer, Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs, J. Biol. Chem. 272 (1997) 3406-3410.
58. C. Jiang, A.T. Ting, B. Seed, PPAR-γ agonists inhibit production of monocyte inflammatory cytokines, Nature 391 (1998) 82-86.
59. R.B. Clark, D. Bishop-Bailey, T. Estrada-Hernandez, T. Hla, L. Puddington, S.J. Padula, The nuclear PPARγ and immunoregulation: PPARγ mediates inhibition of helper T cell responses, J. Immunol. 164 (2000) 1364-1371.
60. B. Haribabu, D.V. Zhelev, B.C. Pridgen, R.M. Richardson, H. Ali, R. Snyderman, Chemoattractant receptors activate distinct pathways for chemotaxis and secretion. Role of G-protein usage, J. Biol. Chem. 274 (1999) 37087-37092.
61. E.J. Neer, Heterotrimeric G proteins: organizers of transmembrane signals, Cell 80 (1995) 249-257.
62. 2 receptors CRTH2 and DP, J. Allergy Clin. Immunol. 108 (2001) 982-988.
63. 2 analogs on the pulmonary and systemic circulations in the conscious newborn lamb, Prostaglandins 27 (1984) 535-542.
64. 2 as a mediator of allergic asthma, Science 287 (2000) 2013-2017.
65. M.N. Ajuebor, A. Singh, J.L. Wallace, Cyclooxygenase-2-derived prostaglandin D(2) is an early anti-inflammatory signal in experimental colitis, Am. J. Physiol. Gastrointest. Liver Physiol. 279 (2000) G238-244.
66. 2 in the inhibition of epidermal Langerhans cell migration during schistosomiasis infection, J. Exp. Med. 193 (2001) 1135-1147.
67. A. Mizoguchi, N. Eguchi, K. Kimura, et al., Dominant localization of prostaglandin D receptors on arachnoid trabecular cells in mouse basal forebrain and their involvement in the regulation of non-rapid eye movement sleep, Proc. Natl. Acad. Sci. USA 98 (2001) 11674-11679.
68. E.C. Butcher, L.J. Picker, Lymphocyte homing and homeostasis, Science 272 (1996) 60-66.
69. 2) on circulating eosinophils, Prostaglandins Leukot. Med. 15 (1984) 387-397.
70. 2 causes accumulation of eosinophils in the lumen of the dog trachea, J. Appl. Physiol. 67 (1989) 959-962.
71. A. Anthony, A.P. Dhillon, G. Nygard, et al., Early histological features of small intestinal injury induced by indomethacin, Aliment. Pharmacol. Ther. 7 (1993) 29-39.
72. 2 inhibits fibroblast migration, Eur. Respir. J. 19 (2002) 684-689.
73. D.W. Gilroy, P.R. Colville-Nash, D. Willis, J. Chivers, M.J. Paul-Clark, D.A. Willoughby, Inducible cyclooxygenase may have anti-inflammatory properties, Nat. Med. 5 (1999) 698-701.
74. D.H. Wright, A.W. Ford-Hutchinson, K. Chadee, K.M. Metters, The human prostanoid DP receptor stimulates mucin secretion in LS174T cells, Br. J. Pharmacol. 131 (2000) 1537-1545.
75. Y. Fujitani, Y. Kanaoka, K. Aritake, N. Uodome, K. Okazaki-Hatake, Y. Urade, Pronounced eosinophilic lung inflammation and Th2 cytokine release in human lipocalin-type prostaglandin D synthase transgenic mice, J. Immunol. 168 (2002) 443-449.
76. A. Mantovani, F. Colotta, S. Sozzani, P. Allavena, E. Dejana, Vasodilation in multistep paradigm of leucocyte extravasation, Lancet 343 (1994) 1499-1500.